Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05128630
Title Chemo-immunotherapy, Hypo-fractionated RT and Maintenance Immunotherapy for Stage III NSCLC. (DEDALUS)
Acronym DEDALUS
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors IRCCS Policlinico S. Matteo
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.